Page last updated: 2024-09-05

solifenacin succinate and Bladder Cancer

solifenacin succinate has been researched along with Bladder Cancer in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hodgkinson, L1
Walton, A1
Cao, Z; Guo, F; Pan, A; Peng, S; Sun, Y; Wang, H; Wang, L; Wei, R; Xu, C; Zhang, C; Zhang, Z1
Chung, JM; Ha, HK; Joo, J; Kim, DH; Kim, S; Kim, SH; Seo, HK; Sohn, DW1

Trials

2 trial(s) available for solifenacin succinate and Bladder Cancer

ArticleYear
Solifenacin is able to improve the irritative symptoms after transurethral resection of bladder tumors.
    Urology, 2014, Volume: 84, Issue:1

    Topics: Cystectomy; Cystitis; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Prospective Studies; Quinuclidines; Remission Induction; Single-Blind Method; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder Diseases; Urinary Bladder Neoplasms; Urinary Bladder, Overactive; Urination Disorders

2014
Evaluation of the Efficacy of Solifenacin for Preventing Catheter-Related Bladder Discomfort After Transurethral Resection of Bladder Tumors in Patients With Non-Muscle Invasive Bladder Cancer: A Prospective, Randomized, Multicenter Study.
    Clinical genitourinary cancer, 2017, Volume: 15, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Pain, Postoperative; Prospective Studies; Severity of Illness Index; Solifenacin Succinate; Treatment Outcome; Urinary Bladder Neoplasms; Urinary Catheterization; Urological Agents

2017

Other Studies

2 other study(ies) available for solifenacin succinate and Bladder Cancer

ArticleYear
American Urological Association (AUA) - 112th Annual Meeting (May 12-16, 2017 - Boston, Massachusetts, USA).
    Drugs of today (Barcelona, Spain : 1998), 2017, Volume: 53, Issue:6

    Topics: Acetanilides; Administration, Intranasal; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Carcinoma, Transitional Cell; Clinical Trials, Phase III as Topic; Deamino Arginine Vasopressin; Delayed-Action Preparations; Double-Blind Method; Drug Combinations; Humans; Hydrogels; Mitomycin; Multicenter Studies as Topic; Nocturia; Randomized Controlled Trials as Topic; Solifenacin Succinate; Thiazoles; United States; Urinary Bladder Neoplasms; Urinary Bladder, Overactive; Urology

2017
Managing overactive bladder symptoms in a palliative care setting.
    Journal of palliative medicine, 2014, Volume: 17, Issue:1

    Topics: Aged, 80 and over; Butylscopolammonium Bromide; Cholinergic Antagonists; Humans; Incontinence Pads; Male; Muscarinic Antagonists; Palliative Care; Quality of Life; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder Neoplasms; Urinary Bladder, Overactive; Urinary Tract Infections

2014